FDA Chastises Novartis Unit Over Safety Issues
The U.S. Food and Drug Administration has sent a warning letter to the vaccine-making subsidiary of Novartis AG over a number of "significant deviations" from quality-control practices at one of the...To view the full article, register now.
Already a subscriber? Click here to view full article